Glenmede Trust’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,245
| Closed | -$207K | – | 1302 |
|
|
2022
Q3 | $207K | Buy |
+9,245
| New | +$207K | ﹤0.01% | 1079 |
|
|
2020
Q4 | – | Sell |
-742
| Closed | -$29K | – | 1553 |
|
|
2020
Q3 | $29K | Buy |
742
+712
| +2,373% | +$27.8K | ﹤0.01% | 1469 |
|
|
2020
Q2 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 2320 |
|
|
2019
Q1 | – | Sell |
-1,070
| Closed | -$13 | – | 3087 |
|
|
2018
Q4 | $13 | Buy |
+1,070
| New | +$13 | ﹤0.01% | 2169 |
|
|
2018
Q3 | – | Sell |
-3,420
| Closed | -$39K | – | 1573 |
|
|
2018
Q2 | $39K | Buy |
+3,420
| New | +$39K | ﹤0.01% | 1525 |
|